{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-23-000097","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.843445+00:00","generated_at":"2026-06-11T21:06:58.889599+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"INNOVATE Q2 net loss narrows to $10.5M; CEO Wayne Barr passes, Paul Voigt appointed","bullets":["Net loss attributable to common stockholders improved to $10.5M ($0.13/share) from $13.6M loss a year ago.","Total adjusted EBITDA rose 36% to $16.5M; Infrastructure segment (DBM Global) posted $23.5M adj EBITDA.","CEO Wayne Barr Jr. passed away; Paul Voigt appointed as CEO (previously President of Infrastructure).","DBM Global revenue $362.4M, backlog $1.5B; MediBeacon filed Phase 3 Transdermal GFR Study Report with FDA.","Purchased DBM Global Series A Preferred from CGIC for $42.2M ($7.1M cash + $35.1M note due 2026)."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-23-000097","json":"https://secwatch.observer/filing/0001006837-23-000097.json","markdown":"https://secwatch.observer/filing/0001006837-23-000097.md","text":"https://secwatch.observer/filing/0001006837-23-000097.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683723000097/0001006837-23-000097-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683723000097/hchc-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:06:58.889599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3808d515598788cc98ec09bc80bef37215fb21be","claim":"INNOVATE Corp. reported the three and six months ended June 30, 2023 results: revenue $368.8 million, net income $(10.5) million, EPS $(0.13) per fully diluted share.","evidence_excerpt":"$ 16.5 $ 12.1 36.4 % $ 21.4 $ 23.6 (9.3) % (1) Reconciliation of GAAP to Non-GAAP measures follows Commentary “INNOVATE reported strong second quarter results with revenue of $368.8 million and adjusted EBITDA of $16.5 million, as our operating segments are capitalizing on attractive market opportunities,\" said Avie Glazer, Chairman of INNOVATE. “The strength in the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006837/000100683723000097/0001006837-23-000097-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Revenue","value":"$368.8 million"},{"label":"Net income","value":"$(10.5) million"},{"label":"EPS","value":"$(0.13) per fully diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}